D. B. Polk and R. M. Peek, Helicobacter pylori: gastric cancer and beyond, Nature Reviews Cancer, vol.10, issue.6, pp.403-417, 2010.

J. K. Hooi, W. Y. Lai, W. K. Ng, M. M. Suen, F. E. Underwood et al.,

D. Y. Malfertheiner, V. W. Graham, J. C. Wong, F. K. Wu, J. J. Chan et al.,

S. C. Kaplan and . Ng, Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis, Gastroenterology, vol.153, issue.2, pp.420-429, 2017.

K. Kotilea, P. Bontems, E. Touati, and . Epidemiology, Diagnosis and Risk Factors of Helicobacter pylori Infection, Helicobacter pylori in Human Diseases: Advances in Microbiology, vol.11, pp.17-33, 2019.
URL : https://hal.archives-ouvertes.fr/pasteur-02868133

M. Leja, I. Grinberga-derica, C. Bilgilier, and C. Steininger, Review: Epidemiology of Helicobacter pylori infection, Helicobacter, vol.24, p.12635, 2019.

P. Malfertheiner, F. Megraud, C. A. O'morain, J. P. Gisbert, E. J. Kuipers et al., Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report, vol.66, pp.6-30, 2017.

K. Sugano, J. Tack, E. J. Kuipers, D. Y. Graham, E. M. El-omar et al., faculty members of Kyoto Global Consensus, Kyoto global consensus report on Helicobacter pylori gastritis, Gut, vol.64, issue.9, pp.1353-67, 2015.

K. Fukase, M. Kato, S. Kikuchi, K. Inoue, N. Uemura et al.,

S. Amagai, M. Hayashi, and . Asaka, Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial, The Lancet, vol.372, issue.9636, pp.392-397, 2008.

Y. C. Lee, T. H. Chen, H. M. Chiu, C. T. Shun, H. Chiang et al., The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention, Gut, vol.62, issue.5, pp.676-82, 2013.

A. C. Ford, D. Forman, R. H. Hunt, Y. Yuan, and P. Moayyedi, Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials, BMJ, vol.348, p.3174, 2014.

B. C. Wong, S. K. Lam, W. M. Wong, J. S. Chen, T. T. Zheng et al., Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China. A Randomized Controlled Trial, The Journal of the American Medical Association, vol.291, pp.187-194, 2004.

H. Jaka, A. Mueller, C. Kasang, and S. E. Mshana, Predictors of triple therapy treatment failure among H. pylori infected patients attending at a tertiary hospital in Northwest Tanzania: a prospective study, Bmc Infect Dis, vol.19, 2019.

A. Connor, J. P. Gisbert, C. O'morain, and S. Ladas, Treatment of Helicobacter pylori Infection, Helicobacter, vol.20, pp.54-61, 2015.

S. G. Lim, R. W. Park, S. J. Shin, D. Yoon, J. K. Kang et al.,

K. M. Kim and . Lee, The relationship between the failure to eradicate Helicobacter pylori and previous antibiotics use, Digestive and Liver Disease, vol.48, issue.4, pp.385-390, 2016.

M. Zamani, F. Ebrahimtabar, V. Zamani, W. H. Miller, R. Alizadeh-navaei et al., Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection, Aliment Pharm Ther, vol.47, issue.7, pp.868-876, 2018.

I. C. Gonçalves, P. C. Henriques, C. L. Seabra, and M. C. Martins, The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection, Expert Review Anti-Infective Therapy, vol.12, issue.8, pp.981-92, 2014.

M. Safavi, R. Sabourian, and A. Foroumadi, Treatment of Helicobacter pylori infection: Current and future insights, World Journal of Clinical Cases, vol.4, issue.1, pp.5-19, 2016.

S. Y. Kim, D. J. Choi, and J. Chung, Antibiotic treatment for Helicobacter pylori : Is the end coming?, World Journal of Gastrointestinal Pharmacology and Therapeutics, vol.6, issue.4, pp.183-198, 2015.

T. Niaz, A. Ihsan, R. Abbasi, S. Shabbir, T. Noor et al., Chitosan-albumin based core shell-corona nano-antimicrobials to eradicate resistant gastric pathogen, International Journal of Biological Macromolecules, vol.138, pp.1006-1018, 2019.

S. Devi, E. Rajakumara, and N. Ahmed, Induction of Mincle by Helicobacter pylori and consequent anti-inflammatory signaling denote a bacterial survival strategy, Scientific Reports, vol.5, p.15049, 2015.

A. Magalhaes, R. Marcos-pinto, A. V. Nairn, M. Rosa, R. M. Ferreira et al., Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways, Biochimica et Biophysica Acta (BBA) -Molecular Basis of Disease, vol.1852, issue.9, pp.1928-1967, 2015.

C. Y. Kao, B. S. Sheu, and J. J. Wu, Helicobacter pylori infection: An overview of bacterial virulence factors and pathogenesis, Biomedical Journal, vol.39, issue.1, pp.14-23, 2016.

M. Amieva and R. M. Peek, Pathobiology of Helicobacter pylori-Induced Gastric Cancer, Gastroenterology, vol.150, issue.1, pp.64-78, 2016.

B. Menchicchi, E. Savvaidou, C. Thöle, A. Hensel, and F. M. Goycoolea, Low-Molecular-Weight Dextran Sulfate Nanocapsules Inhibit the Adhesion of Helicobacter pylori to Gastric Cells, ACS Applied Bio Materials, vol.2, issue.11, pp.4777-4789, 2019.

S. Ramteke, N. Ganesh, S. Bhattacharya, and N. K. Jain, Amoxicillin, clarithromycin, and omeprazole based targeted nanoparticles for the treatment of H. pylori, Journal of Drug Targeting, vol.17, issue.3, pp.225-259, 2009.

Z. Wu, J. Hou, Y. Wang, M. Chai, Y. Xiong et al., Preparation and evaluation of amoxicillin loaded dual molecularly imprinted nanoparticles for anti-Helicobacter pylori therapy, International Journal of Pharmaceutics, vol.496, issue.2, pp.1006-1020, 2015.

S. K. Dey, P. K. De, A. De, S. Ojha, R. De et al., Floating mucoadhesive alginate beads of amoxicillin trihydrate: A facile approach for H. pylori eradication, International Journal of Biological Macromolecules, vol.89, pp.622-653, 2016.

N. A. Thombre and P. S. Gide, Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication, Drug Delivery, vol.23, issue.2, pp.405-424, 2016.

A. O. Adebisi and B. R. Conway, Lectin-conjugated microspheres for eradication of Helicobacter pylori infection and interaction with mucus, International Journal of Pharmaceutics, vol.470, issue.1, pp.28-40, 2014.

Y. H. Lin, S. C. Tsai, C. H. Lai, C. H. Lee, Z. S. He et al., Genipin-cross-linked fucose-chitosan/heparin nanoparticles for the eradication of Helicobacter pylori, Biomaterials, vol.34, issue.18, pp.4466-79, 2013.

M. Luo, Y. Y. Jia, Z. W. Jing, C. Li, S. Y. Zhou et al., Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pylori, Colloids Surfaces B Biointerfaces, vol.164, pp.11-19, 2018.

S. Hao, Y. Wang, B. Wang, Q. Zou, H. Zeng et al., A novel gastroretentive porous microparticle for anti-Helicobacter pylori therapy: preparation, in vitro and in vivo evaluation, International Journal of Pharmaceutics, vol.463, issue.1, pp.10-21, 2014.

Y. Lin, J. Lin, S. Chou, S. Chang, C. Chung et al., Berberine-loaded targeted nanoparticles as specific Helicobacter pylori eradication therapy: in vitro and in vivo study, Nanomedicine, vol.10, issue.1, 2015.

P. Li, X. Chen, Y. Shen, H. Li, Y. Zou et al., Mucus penetration enhanced lipid polymer nanoparticles improve the eradication rate of Helicobacter pylori biofilm, Journal of Controlled Release, vol.300, pp.52-63, 2019.

P. Parreira, M. F. Duarte, C. A. Reis, and M. C. Martins, Helicobacter pylori infection: A brief overview on alternative natural treatments to conventional therapy, Critical Reviews in Microbiology, vol.42, issue.1, 2014.

G. Ayala, W. I. Escobedo-hinojosa, C. F. De-la-cruz-herrera, and I. Romero, Exploring alternative treatments for Helicobacter pylori infection, World Journal of Gastroenterology, vol.20, issue.6, pp.1450-69, 2014.

C. L. Seabra, C. Nunes, M. Gomez-lazaro, M. Correia, J. C. Machado et al., Docosahexaenoic acid loaded lipid nanoparticles with bactericidal activity against Helicobacter pylori, International Journal of Pharmaceutics, vol.519, issue.1-2, pp.128-137, 2017.

C. L. Seabra, C. Nunes, M. Bras, M. Gomez-lazaro, C. A. Reis et al., Lipid nanoparticles to counteract gastric infection without affecting gut microbiota, European Journal of Pharmaceutics and Biopharmaceutics, vol.127, 2018.

M. F. Garro, A. G. Salinas-ibanez, A. E. Vega, A. C. Sosa, L. Pelzer et al., Gastroprotective effects and antimicrobial activity of Lithraea molleoides and isolated compounds against Helicobacter pylori, Journal of Ethnopharmacology, vol.176, pp.469-74, 2015.

W. I. Hinojosa, M. A. Quiroz, I. R. Alvarez, P. E. Castaneda, M. L. Villarreal et al.,

. Taketa, Anti-Helicobacter pylori, gastroprotective, anti-inflammatory, and cytotoxic activities of methanolic extracts of five different populations of Hippocratea celastroides collected in Mexico, Journal of Ethnopharmacology, vol.155, issue.2, pp.1156-63, 2014.

M. O. Makobongo, J. J. Gilbreath, and D. S. Merrell, Nontraditional therapies to treat Helicobacter pylori infection, Journal of Microbiology, vol.52, issue.4, pp.259-72, 2014.

B. Menchicchi, A. Hensel, and F. M. Goycoolea, Polysaccharides as Bacterial Antiadhesive Agents and "Smart" Constituents for Improved Drug Delivery Systems Against Helicobacter pylori Infection, Current Pharmaceutical Design, vol.21, issue.33, pp.4888-906, 2015.

Y. Gong, L. Tao, F. Wang, W. Liu, L. Jing et al., Chitosan as an adjuvant for a Helicobacter pylori therapeutic vaccine, Molecular Medicine Reports, vol.12, issue.3, pp.4123-4155, 2015.

M. Zeng, X. Mao, J. Li, W. Tong, B. Wang et al., Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, The Lancet, vol.386, pp.1457-1464, 2015.

A. M. Svennerholm and A. Lundgren, Progress in vaccine development against Helicobacter pylori, FEMS Immunology & Medical Microbiology, vol.50, issue.2, pp.146-56, 2007.

S. J. Czinn and T. Blanchard, Vaccinating against Helicobacter pylori infection, Nature Reviews Gastroenterology & Hepatology, vol.8, issue.3, pp.133-173, 2011.

M. Kong, X. G. Chen, K. Xing, and H. J. Park, Antimicrobial properties of chitosan and mode of action: a state of the art review, International Journal of Food Microbiology, vol.144, issue.1, pp.51-63, 2010.

R. Hejazi and M. Amiji, Chitosan-based gastrointestinal delivery systems, Journal of Controlled Release, vol.89, issue.2, pp.151-165, 2003.

S. Dhawan, A. K. Singla, and V. R. Sinha, Evaluation of Mucoadhesive Properties of Chitosan Microspheres Prepared by Different Methods, vol.5, 2004.

M. Fernandes, I. C. Goncalves, S. Nardecchia, I. F. Amaral, M. A. Barbosa et al.,

. Martins, Modulation of stability and mucoadhesive properties of chitosan microspheres for therapeutic gastric application, International Journal of Pharmaceutics, vol.454, issue.1, pp.116-140, 2013.

P. He, S. S. Davis, and L. Illum, In vitro evaluation of the mucoadhesive properties of chitosan microspheres, International Journal of Pharmaceutics, vol.166, pp.75-68, 1998.

C. Lehr, J. A. Bouwstra, E. H. Schacht, and H. E. Junginger, In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers, International Journal of Pharmaceutics, vol.78, pp.43-48, 1992.

S. Hirano and N. Nagao, Effects of Chitosan, Pectic Acid, Lysozyme, and Chitinase on the Growth of Several Phytopathogens, Agricultural and Biological Chemistry, vol.53, issue.11, pp.3065-3066, 1989.

Y. Jiao, X. Pang, M. Liu, B. Zhang, L. Li et al., Recent progresses in bioadhesive microspheres via transmucosal administration, Colloids Surfaces B, vol.140, pp.361-72, 2016.

D. Luo, J. Guo, F. Wang, J. Sun, G. Li et al., Preparation and evaluation of anti-Helicobacter pylori efficacy of chitosan nanoparticles in vitro and in vivo, Journal of Biomaterials Science, vol.20, issue.11, pp.1587-96, 2009.

F. Nogueira, I. C. Goncalves, and M. C. Martins, Effect of gastric environment on Helicobacter pylori adhesion to a mucoadhesive polymer, Acta Biomaterialia, vol.9, issue.2, pp.5208-5223, 2013.

I. C. Gonçalves, A. Magalhães, M. Fernandes, I. V. Rodrigues, C. A. Reis et al.,

. Martins, Bacterial-binding chitosan microspheres for gastric infection treatment and prevention, Acta Biomaterialia, vol.9, issue.12, pp.9370-9378, 2013.

I. C. Gonçalves, A. Magalhães, A. M. Costa, J. R. Oliveira, P. C. Henriques et al., Bacteria-targeted biomaterials: Glycan-coated microspheres to bind Helicobacter pylori, Acta Biomaterialia, vol.33, pp.40-50, 2016.

M. R. Amieva and E. M. El-omar, Host-bacterial interactions in Helicobacter pylori infection, Gastroenterology, vol.134, issue.1, pp.306-329, 2008.

J. R. Oliveira, M. C. Martins, L. Mafra, and P. Gomes, Synthesis of an O-alkynylchitosan and its chemoselective conjugation with a PEG-like amino-azide through click chemistry, Carbohydrate Polymers, vol.87, issue.1, pp.240-249, 2012.

I. F. Amaral, P. L. Granja, and M. A. Barbosa, Chemical modification of chitosan by phosphorylation: an XPS, FT-IR and SEM study, Journal of Biomaterials Science, vol.16, issue.12, pp.1575-1593, 2005.

J. Brugnerotto, J. Lizardi, F. M. Goycoolea, W. Arguelles-monal, J. Desbrieres et al., An infrared investigation in relation with chitin and chitosan characterization, Polymer, vol.42, issue.8, pp.3569-3580, 2001.
URL : https://hal.archives-ouvertes.fr/hal-01585443

A. Lee, J. O'rourke, M. C. De-ungria, B. Robertson, G. Daskalopoulos et al., A standardized mouse model of Helicobacter pylori infection: Introducing the Sydney strain, Gastroenterology, vol.112, issue.4, pp.1386-1397, 1997.

J. Mahdavi, B. Sonden, M. Hurtig, F. O. Olfat, L. Forsberg et al.,

A. Berg, C. Dubois, K. E. Petersson, T. Magnusson, F. Norberg et al., Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation, Science, vol.297, issue.5581, pp.573-581, 2002.

P. Falk, K. A. Roth, T. Boren, T. U. Westblom, J. I. Gordon et al., An invitro adherence assay reveals that Helicobacter pylor exhibits cell lineage-specific tropism in the human gastric epithelium (host-crobil lnteractlons/adheslns/glycoproteins/gastrlc epithelial cell biolgy, Proceedings of the National Academy of Sciences of the USA 90, pp.2035-2039, 1993.

P. Parreira, A. Magalhaes, I. C. Goncalves, J. Gomes, R. Vidal et al., Effect of surface chemistry on bacterial adhesion, viability, and morphology, Journal of Biomedical Materials Research A, vol.99, issue.3, pp.344-53, 2011.

, Sample preparation and reference materials, Biological evaluation of medical devices, Part, vol.12, pp.10993-11005, 2004.

, Biological evaluation of medical devices Part 5, Tests for in vitro cytotoxicity, pp.10993-10998, 2009.

S. A. Miller, D. D. Dykes, and H. F. Polesky, A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Research, vol.16, issue.3, 1988.

M. Hammar, T. Tyszkiewicz, T. Wadstrom, and P. W. O'toole, Rapid Detection of Helicobacter pylori in Gastric Biopsy Material by Polymerase Chain Reaction, Journal of Clinical Microbiology, vol.30, issue.1, pp.54-58, 1992.

J. Y. Hou, L. N. Gao, F. Y. Meng, and Y. L. Cui, Mucoadhesive microparticles for gastroretentive delivery: preparation, biodistribution and targeting evaluation, Marine Drugs, vol.12, issue.12, pp.5764-87, 2014.

S. Thamphiwatana, W. Gao, M. Obonyo, and L. Zhang, In vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammation, Proceedings of the National Academy of Sciences of the USA, vol.111, issue.49, pp.17600-17605, 2014.

N. R. Salama, G. Otto, L. Tompkins, and S. Falkow, Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection, Infection and Immunity, vol.69, issue.2, pp.730-736, 2001.

R. L. Ferrero, J. Thiberge, M. Huerre, and A. Labigne, Immune Responses of Specific-Pathogen-Free Mice to Chronic Helicobacter pylori (Strain SS1) Infection, Infection and Immunity, vol.66, issue.4, pp.1349-1355, 1998.

E. Touati, V. Michel, M. Correia, L. Menghini, S. Genovese et al., Boropinic acid, a novel inhibitor of Helicobacter pylori stomach colonization, Journal of Antimicrobial Chemotherapy, vol.64, issue.1, pp.210-211, 2009.

C. R. Silva, V. Michel, S. Genovese, M. C. Prevost, F. Epifano et al., Anti-Helicobacter pylori activities of natural isopentenyloxycinnamyl derivatives from Boronia pinnata, Nature Product Communications, vol.7, issue.10, pp.1347-50, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-01737658

S. Salillas, M. Alias, V. Michel, A. Mahia, A. Lucia et al., Design, Synthesis, and Efficacy Testing of Nitroethylene-and 7-Nitrobenzoxadiazol-Based Flavodoxin Inhibitors against Helicobacter pylori Drug-Resistant Clinical Strains and in Helicobacter pylori-Infected Mice, Journal of Medicinal Chemistry, vol.62, issue.13, pp.6102-6115, 2019.
URL : https://hal.archives-ouvertes.fr/pasteur-02868148

M. Correia, V. Michel, A. A. Matos, P. Carvalho, M. J. Oliveira et al., Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization, Plos One, vol.7, issue.4, p.35072, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01651966

S. I. Smith, K. S. Oyedeji, A. O. Arigbabu, F. Cantet, F. Megraud et al., Comparison of three PCR methods for detection of Helicobacter pylori DNA and detection of cagA gene in gastric biopsy specimens, World Journal of Gastroenteroly, vol.10, issue.13, pp.1958-1960, 2004.

P. M. Treuting, M. A. Valasek, and S. M. Dintzis, Comparative Anatomy and Histology: A Mouse and Human Atlas, pp.155-175, 2012.

X. Cai, J. Carlson, C. Stoicov, H. Li, T. C. Wang et al., Helicobacter felis Eradication Restores Normal Architecture and Inhibits Gastric Cancer Progression in C57BL/6 Mice, Gastroenterology, vol.128, issue.7, pp.1937-1952, 2005.

M. Rangel, J. C. Martins, A. N. Garcia, G. A. Conserva, A. Costa-neves et al.,

L. R. Sant'anna and . De-carvalho, Analysis of the toxicity and histopathology induced by the oral administration of Pseudanabaena galeata and Geitlerinema splendidum (cyanobacteria) extracts to mice, Mar Drugs, vol.12, issue.1, pp.508-532, 2014.

R. R. Seeley, T. D. Stephans, and P. Tate, Anatomy and Physiology

F. Mi, H. Sung, S. Shyu, C. Su, and C. Peng, Synthesis and characterization of biodegradable TPP/genipin co-crosslinked chitosan gel beads, Polymer, vol.44, issue.21, pp.6521-6530, 2003.

H. Takeuchi, H. Yamamoto, and Y. Kawashima, Mucoadhesive nanoparticulate systems for peptide drug delivery, Advanced Drug Delivery Reviews, vol.47, pp.39-54, 2001.

S. K. Lai, Y. Y. Wang, and J. Hanes, Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues, Advanced Drug Delivery Reviews, vol.61, issue.2, pp.158-71, 2009.

L. M. Ensign, R. Cone, and J. Hanes, Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers, Advanced Drug Delivery Reviews, vol.64, issue.6, pp.557-70, 2012.

S. K. Lai, D. E. O'hanlon, S. Harrold, S. T. Man, Y. Y. Wang et al., Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus, P Natl Acad Sci, vol.104, issue.5, pp.1482-1487, 2007.

M. A. Elgadir, M. S. Uddin, S. Ferdosh, A. Adam, A. J. Chowdhury et al., Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: A review, Journal of Food and Drug Analysis, vol.23, issue.4, pp.619-629, 2015.

S. Arora, S. Gupta, R. K. Narang, and R. D. Budhiraja, Amoxicillin loaded chitosanalginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for H. pylori, Scientific Pharmaceutics, vol.79, issue.3, pp.673-94, 2011.

A. Sadio, J. K. Gustafsson, B. Pereira, C. P. Gomes, G. C. Hansson et al., Modified-Chitosan/siRNA Nanoparticles Downregulate Cellular CDX2 Expression and Cross the Gastric Mucus Barrier, Plos One, vol.9, issue.6, 2014.

D. E. Chickering, J. S. Jacob, T. A. Desai, M. Harrison, W. P. Harris et al., Bioadhesive microspheres: III. An in vivo transit and bioavailability study of drug-loaded alginate and poly(fumaric-co-sebacic anhydride) microspheres, Journal of Controlled Release, vol.48, pp.35-46, 1997.

E. I. Rabea, M. E. Badawy, C. V. Stevens, G. Smagghe, and W. Steurbaut, Chitosan as Antimicrobial Agent: Applications and Mode of Action, vol.4, 2003.

R. A. Cone, Barrier properties of mucus, Advanced Drug Delivery Reviews, vol.61, issue.2, pp.75-85, 2009.

M. M. Amiji, Tetracycline-containing Chitosan Microspheres for Local Treatment of Helicobacter pylori Infection, Cellulose, vol.14, issue.1, pp.3-14, 2006.

S. E. Ladirat, H. A. Schols, A. Nauta, M. H. Schoterman, B. J. Keijser et al., High-throughput analysis of the impact of antibiotics on the human intestinal microbiota composition, Journal of Microbiological Methods, vol.92, issue.3, pp.387-97, 2013.

I. Adamsson, C. Edlund, and C. E. Nord, Impact of treatment of Helicobacter pylori on the normal gastrointestinal microflora, Clinical Microbiology and Infection, vol.6, issue.4, 2000.